By Dr Farid Kamal, Consultant Oncologist, SEA Hospital ,
Cancer remains one of the leading causes of death worldwide, and Malaysia is no exception. With increasing cancer incidences in both developed and developing regions, the need for more effective prevention, diagnosis, and treatment options has never been more urgent. Malaysia’s healthcare system has made significant progress in providing cancer care to its population, but when it comes to cancer research, there are several challenges that still need to be addressed.
From funding to collaboration and infrastructural limitations, the landscape of cancer research in Malaysia presents both significant hurdles and opportunities for improvement.
Current State of Cancer Research in Malaysia
Cancer in Malaysia has risen as a major public health concern, and the numbers are staggering. According to the Malaysian National Cancer Registry, cancer is the third leading cause of death in the country. The most common types of cancer in Malaysia include breast cancer, colorectal cancer, and lung cancer. While the statistics are alarming, the good news is that the country has started to prioritize cancer treatment and research in recent years.
Government agencies, academic institutions, and some private organizations have initiated various research projects to better understand the causes and behavior of cancer in the Malaysian context. For instance, Universiti Malaya (UM), Universiti Kebangsaan Malaysia (UKM), and the Cancer Research Malaysia (CRM) have been active in cancer research, studying local cancer incidence rates, genetics, and the effectiveness of treatments in Malaysia’s multi-ethnic population. These institutions are collaborating with international counterparts to develop targeted therapies and prevention strategies.
Despite these efforts, Malaysia’s cancer research is still in its early stages compared to more developed countries. One of the key challenges lies in the relatively limited funding for cancer research. Unlike countries such as the United States, where both government agencies and private investors pump billions into cancer research, Malaysia’s investment in this field is modest, and often dependent on limited government grants or collaborations with external organizations. In turn, this lack of financial backing restricts the country’s ability to drive more extensive research, as well as access to the latest technology and specialized expertise.
The Role of Government and Funding
The Malaysian government has made some strides in supporting cancer research through initiatives like the National Cancer Control Plan (NCCP) and the National Institutes of Health (NIH), but there is still much room for improvement. Malaysia’s cancer research community often relies heavily on public health funding, which is distributed across a wide range of diseases and conditions. As a result, cancer research does not always receive the dedicated resources it needs for innovation and breakthroughs.
A more focused effort from the government is needed to strengthen the infrastructure for cancer research. In the long run, this would allow researchers to better understand the genetic and environmental factors contributing to cancer within Malaysia’s diverse ethnic populations. It could also provide the means for the development of precision medicine, tailored treatments that could significantly improve patient outcomes.
Moreover, government funding should be paired with greater private sector involvement. Malaysia’s corporate sector can play a larger role in fostering cancer research by
